We are live on ! Find out more
NAVB

Navidea Biopharmaceuticals Inc.
NAVB

Delisted

NAVB was delisted on the 5th of October, 2023.

Back to rankings

31 hedge funds and large institutions have $3.13M invested in Navidea Biopharmaceuticals Inc. in 2021 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 11 increasing their positions, 5 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

120% more repeat investments, than reductions

Existing positions increased: 11 | Existing positions reduced: 5

11% less funds holding

Funds holding: 35 → 31 (-4)

17% less capital invested

Capital invested by funds: $3.77M → $3.13M (-$647K)

32% less call options, than puts

Call options by funds: $385K | Put options by funds: $566K

50% less first-time investments, than exits

New positions opened: 4 | Existing positions closed: 8

Holders
31
Holders Change
-4
Holders Change %
-11.43%
% of All Funds
0.54%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
11
Reduced
5
Closed
8
Calls
$385K
Puts
$566K
Net Calls
-$181K
Net Calls Change
-$160K

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$72.4K
2
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$52.3K
3
Two Sigma Advisers
Two Sigma Advisers
New York
+$45.6K
4
State Street
State Street
Massachusetts
+$42.1K
5
Geode Capital Management
Geode Capital Management
Massachusetts
+$39K

Top Sellers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
-$266K
2
BCM
Bridgeway Capital Management
Texas
-$177K
3
Two Sigma Investments
Two Sigma Investments
New York
-$73K
4
Squarepoint
Squarepoint
New York
-$58K
5
Group One Trading
Group One Trading
Illinois
-$49.2K
Name Holding Trade Value Shares
Change 		Change in
Stake
Renaissance Technologies
26
Renaissance Technologies
New York
– -$266K -131,618 Closed
Squarepoint
27
Squarepoint
New York
– -$58K -28,836 Closed
California Public Employees Retirement System
28
California Public Employees Retirement System
California
– -$37K -18,385 Closed
Wolverine Trading
29
Wolverine Trading
Illinois
– -$22K -11,219 Closed
SFS
30
Sowell Financial Services
Arkansas
– -$18K -11,190 Closed
TRCT
31
Tower Research Capital (TRC)
New York
– -$2K -783 Closed
CFFP
32
Center for Financial Planning
Michigan
– +$16 +9 New
ASN
33
Advisory Services Network
Georgia
– +$442 +250 New
1
2

NAVB Hedge Fund Activity: Q2 2021 in Review

31 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Navidea Biopharmaceuticals Inc. (NAVB) for Q2 2021, worth a combined $3.13M — down 17% from $3.77M a quarter earlier.

Sellers outnumbered buyers: 8 funds closed out of NAVB and 4 opened new positions — a net loss of 4 holders — while 5 trimmed existing stakes and 11 added.

The largest buyer was BlackRock, adding an estimated $72.4K. The largest seller was Renaissance Technologies, exiting entirely with an estimated $266K sold.

  • 31 institutional investors held Navidea Biopharmaceuticals Inc. (NAVB) as of Q2 2021, down from 35 in Q1 2021.
  • Funds reported $3.13M of Navidea Biopharmaceuticals Inc. stock for Q2 2021, down 17% quarter-over-quarter.
  • 4 funds opened new Navidea Biopharmaceuticals Inc. positions in Q2 2021 and 8 closed out, a net change of -4 holders.
  • The largest Navidea Biopharmaceuticals Inc. buyer in Q2 2021 was BlackRock, an estimated $72.4K added.
  • The largest Navidea Biopharmaceuticals Inc. seller in Q2 2021 was Renaissance Technologies, an estimated $266K sold.

Based on aggregated 13F filings for Q2 2021.